Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2024-07-29 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺-吴乔
Board/Management Information Classification · 95% confidence The document is a formal declaration and commitment statement by an independent director candidate for a company's board. It details the candidate's qualifications, compliance with regulatory requirements, and commitments related to the role of an independent director. There are no financial statements, earnings data, or report summaries present. The content is related to board/management information, specifically about a board member candidate's declaration and compliance. This fits the category of Board/Management Information (MANG). The document length is 4247 characters, which is sufficient for a detailed declaration but not a full report. Therefore, the classification is MANG with high confidence.
2024-07-29 Chinese
独立董事提名人声明与承诺-王恩华
Board/Management Information Classification · 95% confidence The document is a formal statement from the board of directors nominating an independent director candidate for the company's board. It includes detailed declarations and commitments regarding the nominee's qualifications, independence, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report content. The document is related to board/management information, specifically about a change or nomination in the company's board of directors. The document length is 4264 characters, which is relatively short and focused on nomination statements rather than a full report or announcement of a report publication. Therefore, the most appropriate classification is Board/Management Information (MANG).
2024-07-29 Chinese
董事会提名委员会关于第四届董事会董事候选人任职资格的审查意见
Board/Management Information Classification · 95% confidence The document is an official announcement from the Board Nomination Committee regarding the qualification review of candidates for the company's fourth board of directors. It discusses the eligibility and compliance of non-independent and independent director candidates according to relevant laws and regulations. There is no financial data, no mention of financial results, no report attached or referenced, and no indication of a meeting or voting results. This type of document is a board/management information announcement about changes or nominations in the company's board of directors.
2024-07-29 Chinese
2024年半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 90% confidence The document is a detailed tabular summary of non-operating fund occupation and other related party fund transactions for the half-year period of 2024. It includes financial figures such as balances, cumulative amounts, interest, repayments, and ending balances for various related parties and subsidiaries. The document is a financial summary report for a specific interim period (half-year) and contains substantive financial data and analysis. It is not an announcement or a brief summary but a detailed financial report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 2355 characters, which is relatively short but contains actual financial data, so it is not a report publication announcement or regulatory filing. Hence, the classification is IR with high confidence.
2024-07-29 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a meeting resolution announcement from the Supervisory Board of Xiamen Aide Biomedical Technology Co., Ltd. It details the approval of the 2024 semi-annual report and other supervisory board matters such as election of new supervisors and remuneration. The document does not contain the full semi-annual report itself but references that the full report is available on the designated disclosure website. The document length is short (1418 characters) and primarily serves as an announcement of meeting resolutions and approvals rather than the report itself. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2024-07-29 Chinese
关于召开2024年第二次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2024 second extraordinary general meeting of shareholders for Xiamen Aide Bio-Pharmaceutical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including board member elections and remuneration proposals, registration methods, and voting instructions. The content focuses on the organization and conduct of a shareholders meeting, including proposals to be voted on and instructions for shareholders. There is no financial data, earnings information, or audit content. The document is not a report itself but a formal announcement and notice for a shareholders meeting, including proxy and voting details. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is over 6000 characters, indicating it is a full notice rather than a brief announcement. Therefore, the classification is AGM Information (AGM-R) with high confidence.
2024-07-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.